文献速递前列腺癌

匹配配对分析比较传统经直肠超声引导与基于软件的预定义三维引导系统性前列腺穿刺活检

A Matched-pair Analysis Comparing Systematic Prostate Biopsy by Conventional Transrectal Ultrasound-guidance Versus Software-based Predefined 3D-Guidance.
PubMed 文献 · Urology · 2023-04-03

本研究纳入956例无既往阳性活检且前列腺特异性抗原≤20 ng/ml的患者,按1:1倾向性评分匹配比较基于软件的三维引导系统性前列腺活检(3D-GSB)与传统经直肠超声引导系统性活检(TGSB)的前列腺癌检出率。匹配后3D-GSB组总体检出率显著高于TGSB组(55.6% vs 39.9%,P=.002),但临床显著前列腺癌检出率无显著差异(33.3% vs 28.8%,P=.385)。结论认为3D-GSB总体检出率更高,但未显示对临床显著前列腺癌检出有额外价值。

要点

  • 匹配后3D-GSB组总体前列腺癌检出率显著高于TGSB组(55.6% vs 39.9%,P=.002)。
  • 两组临床显著前列腺癌检出率无显著差异(33.3% vs 28.8%,P=.385)。
  • 3D-GSB组非显著前列腺癌检出率显著高于TGSB组(22.2% vs 11.1%,P=.004)。

核心结论

  • 3D-GSB与TGSB相比总体前列腺癌检出率更高,但两种技术对临床显著前列腺癌的检出无显著差异,因此目前3D-GSB似乎未增加传统TGSB的价值。

研究设计与样本

  • 匹配配对分析,共纳入956例无既往阳性活检且前列腺特异性抗原≤20 ng/ml的患者(TGSB组200例,3D-GSB组756例)。
  • 采用倾向性评分匹配以年龄、前列腺特异性抗原、前列腺体积、既往活检状态和可疑触诊发现为混杂因素,按1:1比例匹配TGSB与3D-GSB病例。
  • 3D-GSB使用半机器人前列腺融合活检系统Artemis进行,两组每例患者均以相似模式进行12针系统性活检。
  • 3D-GSB的所有针道均在3D模型及实时经直肠超声图像上自动规划与映射。
  • 主要终点为临床显著和总体前列腺癌检出率,次要终点为癌阳性针道率。

主要发现

  • 匹配后3D-GSB组与TGSB组临床显著前列腺癌检出率无显著差异(33.3% vs 28.8%,P=.385)。
  • 3D-GSB组总体前列腺癌检出率显著高于TGSB组(55.6% vs 39.9%,P=.002)。
  • 3D-GSB组检出的非显著前列腺癌显著多于TGSB组(22.2% vs 11.1%,P=.004)。
  • 在前列腺癌患者中,TGSB组癌阳性系统性活检针道数显著高于3D-GSB组(42% vs 25%,P<.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare software-based three-dimensional-guided systematic prostate biopsy (3D-GSB) with conventional transrectal ultrasound-guided systematic biopsy (TGSB) regarding prostate cancer (PCa) detection rates (CDR). METHODS: In total, 956 patients (200 TGSB patients and 756 3D-GSB patients) without prior positive biopsies and with a prostate-specific antigen value ≤20 ng/ml were eligible for analysis. TGSB and 3D-GSB cases were matched in a 1:1 ratio using propensity score matching with age, prostate-specific antigen, prostate volume, previous biopsy status, and suspicious palpatory finding as confounders. 3D-GSB was conducted with the semi-robotic prostate fusion-biopsy system Artemis. For each patient in both groups, SB was conducted in a similar pattern with 12 cores. All cores in 3D-GSB were automatically planned and mapped on a 3D-model as well as on the real-time transrectal ultrasound imaging. Primary end points were the clinically significant (cs) and overall CDR. Secondary end point was the cancer-positive core rate. RESULTS: After matching, the csCDR was not significantly different between the 3D-GSB and the TGSB groups (33.3% vs 28.8%, P = .385). Overall CDR was significantly higher for 3D-GSB compared to TGSB (55.6% vs 39.9%, P = .002). 3D-GSB detected significantly more non-significant PCa than TGSB (22.2% vs 11.1%, P = .004). In patients with PCa, the number of cancer-positive SB cores was significantly higher by TGSB (42% vs 25%, P < .001). CONCLUSION: 3D-GSB was associated with a higher CDR than TGSB. However, no significant difference was shown in detection of csPCa between both techniques. Therefore, currently, 3D-GSB does not appear to add value to conventional TGSB.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Derigs F, Kowalewski KF, Hartung FO, et al. A Matched-pair Analysis Comparing Systematic Prostate Biopsy by Conventional Transrectal Ultrasound-guidance Versus Software-based Predefined 3D-Guidance. Urology. 2023. PMID: 37019390. doi:10.1016/j.urology.2023.03.027

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。